Subchronic N-acetylcysteine Treatment Decreases Brain Kynurenic Acid Levels and Improves Cognitive Performance in Mice.
AuthorBlanco Ayala, Tonali
Ramírez Ortega, Daniela
Ovalle Rodríguez, Paulina
Pérez de la Cruz, Gonzalo
González Esquivel, Dinora
Sathyasaikumar, Korrapati V.
Jiménez Anguiano, Anabel
Pérez de la Cruz, Verónica
JournalAntioxidants (Basel, Switzerland)
MetadataShow full item record
AbstractThe tryptophan (Trp) metabolite kynurenic acid (KYNA) is an α7-nicotinic and N-methyl-d-aspartate receptor antagonist. Elevated brain KYNA levels are commonly seen in psychiatric disorders and neurodegenerative diseases and may be related to cognitive impairments. Recently, we showed that N-acetylcysteine (NAC) inhibits kynurenine aminotransferase II (KAT II), KYNA's key biosynthetic enzyme, and reduces KYNA neosynthesis in rats in vivo. In this study, we examined if repeated systemic administration of NAC influences brain KYNA and cognitive performance in mice. Animals received NAC (100 mg/kg, i.p.) daily for 7 days. Redox markers, KYNA levels, and KAT II activity were determined in the brain. We also assessed the effect of repeated NAC treatment on Trp catabolism using brain tissue slices ex vivo. Finally, learning and memory was evaluated with and without an acute challenge with KYNA's bioprecursor L-kynurenine (Kyn; 100 mg/kg). Subchronic NAC administration protected against an acute pro-oxidant challenge, decreased KYNA levels, and lowered KAT II activity and improved memory both under basal conditions and after acute Kyn treatment. In tissue slices from these mice, KYNA neosynthesis from Trp or Kyn was reduced. Together, our data indicate that prolonged treatment with NAC may enhance memory at least in part by reducing brain KYNA levels.
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/14689
- N-Acetylcysteine Inhibits Kynurenine Aminotransferase II.
- Authors: Blanco-Ayala T, Sathyasaikumar KV, Uys JD, Pérez-de-la-Cruz V, Pidugu LS, Schwarcz R
- Issue date: 2020 Sep 15
- Assessment of Prenatal Kynurenine Metabolism Using Tissue Slices: Focus on the Neosynthesis of Kynurenic Acid in Mice.
- Authors: Notarangelo FM, Beggiato S, Schwarcz R
- Issue date: 2019
- Inhibition of Large Neutral Amino Acid Transporters Suppresses Kynurenic Acid Production Via Inhibition of Kynurenine Uptake in Rodent Brain.
- Authors: Sekine A, Kuroki Y, Urata T, Mori N, Fukuwatari T
- Issue date: 2016 Sep
- Activation of alpha7 nicotinic and NMDA receptors is necessary for performance in a working memory task.
- Authors: Phenis D, Vunck SA, Valentini V, Arias H, Schwarcz R, Bruno JP
- Issue date: 2020 Jun
- A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats.
- Authors: Koshy Cherian A, Gritton H, Johnson DE, Young D, Kozak R, Sarter M
- Issue date: 2014 Jul